Celgene Corp (CELG) Misses Q1 EPS by 5c; Reaffirms FY2012 Guidance
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Income before income taxes: 256.8M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income before income taxes: 256.8M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q1 EPS of $1.08, $0.05 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.32 billion.
Celgene Corp reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Celgene Corp reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Innovaro (INV) Misses Q2 EPS by 9c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
